Olin Corporation
NYSE:OLNChemicals - Specialty
-$1.00 today
- Market cap
- $1.87B
- Beta
- 1.17
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.12
- Dividend yield
- 3.64%
Volume 2.91M
Average 2.32M
OLN Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Olin CorporationNYSE: OLN
Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other current liabilities remains negative
Q2 FY2026 other current liabilities was $1.54B, compared with $0 a year earlier. Over 3 fiscal years it compounded at -7.0% a year.
Context
- Other current liabilities amounted to 20.7% of total assets at the end of Q2 FY2026, up 20.7 pp from a year earlier.
- Other current liabilities increased in 1 of the last 3 fiscal years.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 197.9M USD
- Year-over-year change
- +66.2%
- 4-year CAGR
- -4.7%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 197.9M | +66.2% |
| FY2024 | 2024-12-31 | 119.1M | -40.3% |
| FY2023 | 2023-12-31 | 199.5M | -19.0% |
| FY2022 | 2022-12-31 | 246.3M | +2.7% |
| FY2021 | 2021-12-31 | 239.8M | — |
Other Current Liabilities vs competitors
How OLN compares with its peers on the latest reported figures
- OLN's Jun 2026 other current liabilities of $1.54B is the highest of the 19 companies compared; the peer median is $39.66M.
- Other current liabilities amounts to 20.7% of total assets for OLN, versus a peer median of 0.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.54B | — | -7.0% | 20.7% | |
| Jun 2026 | $601.8M | +7.0% | +4.7% | 5.2% | |
| Sep 2026 | $404.98M | +813.1% | +14.3% | 13.9% | |
| Apr 2026 | $331.5M | -13.6% | +42.7% | 9.6% | |
| Aug 2026 | $147.78M | +63.7% | — | 2.7% | |
| Mar 2026 | $127.8M | +102.9% | +27.1% | 6.6% | |
| Sep 2026 | $85.72M | +326.7% | +67.1% | 5.0% | |
| Mar 2026 | $67.9M | — | +27.0% | 5.4% | |
| Jun 2026 | $53M | — | +104.6% | 0.3% | |
| Aug 2026 | $49.02M | -74.2% | — | 0.6% | |
| Mar 2026 | $30.3M | +17.0% | -30.7% | 1.7% | |
| Sep 2026 | $0 | +100.0% | +6.9% | 0.0% | |
| Sep 2026 | $0 | -100.0% | +4.0% | 0.0% | |
| Jun 2026 | $0 | — | +4.2% | 0.0% | |
| Jun 2026 | $0 | -100.0% | +0.4% | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | +5.3% | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding OLN) | $39.66M | +12.0% | +6.9% | 0.4% | |
Competitors are the stored peer set for OLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 180.5M | 194M | 170.3M | 175.6M | 167.6M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.11B | 967.8M | 890M | 1.02B | 911.1M |
| Inventory | 868.3M | 941.9M | 858.8M | 823.5M | 784.5M |
| Other Current Assets | 92.7M | 52.7M | 54.1M | 61.4M | 107.9M |
| Total Current Assets | 2.25B | 2.16B | 1.97B | 2.08B | 1.97B |
| Property, Plant & Equipment (Net) | 3.29B | 3.03B | 2.86B | 2.63B | 2.5B |
| Goodwill | 1.42B | 1.42B | 1.42B | 1.42B | 1.43B |
| Intangible Assets | 1.39B | 273.8M | 1.31B | 206.6M | 174.4M |
| Long-term Investments | 7.9M | 4M | 3.2M | 23M | 21.3M |
| Tax Assets | 99.3M | 60.5M | 87.4M | 53.4M | 47.2M |
| Other Non-current Assets | 62.1M | 1.1B | 53.5M | 1.16B | 1.19B |
| Total Non-current Assets | 6.27B | 5.89B | 5.74B | 5.5B | 5.35B |
| Total Assets | 8.52B | 8.04B | 7.71B | 7.58B | 7.33B |
| Account Payables | 847.7M | 837.7M | 775.4M | 861.6M | 806.1M |
| Short-term Debt | 277.9M | 9.7M | 78.8M | 129M | 109.7M |
| Tax Payables | 156.4M | 184.8M | 154.7M | 141.3M | 0 |
| Deferred Revenue | 0 | 41.1M | 34.5M | 23.2M | 38.6M |
| Other Current Liabilities | 239.8M | 246.3M | 199.5M | 119.1M | 197.9M |
| Total Current Liabilities | 1.68B | 1.56B | 1.53B | 1.63B | 1.63B |
| Long-term Debt | 2.58B | 2.57B | 2.59B | 2.71B | 2.72B |
| Deferred Tax Liabilities | 558.9M | 507.3M | 476.2M | 430.5M | 317.6M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 744.3M | 568.4M | 566.1M | 504.6M | 538M |
| Total Non-current Liabilities | 4.18B | 3.94B | 3.92B | 3.89B | 3.83B |
| Total Liabilities | 5.87B | 5.5B | 5.44B | 5.52B | 5.46B |
| Common Stock | 156.8M | 132.3M | 120.2M | 115.7M | 113.6M |
| Retained Earnings | 1.01B | 2.22B | 2.58B | 2.36B | 2.14B |
| Accumulated OCI | (488M) | (495.9M) | (496.3M) | (450.1M) | (414.5M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 35.9M | 32.3M | 31.7M |
| Total Equity | 2.65B | 2.54B | 2.27B | 2.06B | 1.87B |
| Total Debt | 3.16B | 2.95B | 3.02B | 3.15B | 3.14B |
| Net Debt | 2.98B | 2.75B | 2.85B | 2.97B | 2.97B |
Olin Corporation
NYSE:OLN
Intrinsic Alpha fair value
Locked
Current Price
$16.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.